3d极乐宝鉴国语版观看-91激情捆绑调教喷水-99精品网-日日夜夜天天干-2025中文字幕-国产制服丝袜-久久二-免费精品在线视频-九一爱爱-久久久久久久久一区-精品午夜久久久

返回管委會首頁
Home page > Category Report > Industries & Enterprises

Enterprises in Xietang Sub-district demonstrate strong innovation momentum

Date:2026-06-25 12:48:00|Source:|Font Size: AAA

SIP’s Xietang Sub-district is witnessing strong momentum among enterprises in Dongjing Industrial Square and Dongfang Industrial Park, with frequent breakthroughs across its three pillar industries.

In the field of new materials, HSM Technologies unveiled three innovative flame-retardant solutions at the 2026 Flame-Retardant Materials and Technology Forum, effectively addressing key industry challenges and compliance issues.

In the sector of precision electronics, Norautron Suzhou, with over 20 years of experience in reliable PCBA manufacturing for medical electronics, leverages its professional DFM collaborative engineering services to prevent production risks from the R&D stage while ensuring robust supply chain and lifecycle management.

In biomedicine, BIOSURF brought its proprietary precast protein gels into market, enabling protein electrophoresis experiments to be more accurate and efficient for life science research. The company also signed an agreement with a national key laboratory for bio-inspired interfacial material science to jointly establish a lab focused on research of bio-materials surface and interface engineering.

STMed Technology is participating in the development of a key laboratory in Beijing for care and rehabilitation of children with serious illness, focusing on intelligent extracorporeal life support technologies and clinical translation.

BEAVER Biomedical, in collaboration with XJTLU (Xi’an Jiaotong-Liverpool University) Wisdom Lake Academy of Pharmacy, achieved a major research breakthrough, published in the May 2026 issue of the Journal of Separation Science.

RainSure Scientific (Suzhou) presented its latest advances in rapid molecular diagnostics at the Second Unite for Sepsis Symposium held in Washington, D.C. from June 11 to 12.


On June 8, Humatrix completed full patient enrollment in the nationwide multi-center clinical trial for its LineMatrix?, a bioartificial blood vessel.

June 24, 2026

Copyright ? www.swimbuy.cn   |  Contact us